Proffered paper session on head & neck cancer
In this video, Dr Pieterjan Vanclooster discusses and comments on the data of some interesting studies presented at ESMO 2024 during the proffered paper session on head & neck cancer.
From 13 till 17 September 2024: HIGHLIGHTS FROM ESMO
Your direct line with Barcelona
The European Society of Medical Oncology (ESMO) 2024 brings together leading experts in the different fields of cancer from around the world. And this year they gather together in Barcelona, Spain. The MediMix team is also onsite, and will – together with your Belgian colleagues – keep you posted about the hottest topics as they happen. And, we dive into posters and hot topics with the experts as they are being presented.
Stay tuned, and get ready for an exciting and informative journey!
Daily highlights in head & neck
In this video, Dr Pieterjan Vanclooster discusses and comments on the data of some interesting studies presented at ESMO 2024 during the proffered paper session on head & neck cancer.
For his discussion of the mini-oral session on head and neck cancer at ESMO 2024, Dr Michael Saerens, medical oncologist at the University Hospital Ghent selected five interesting presentations.
In-depth stories about head & neck
In this video, Dr Willem Lybaert and Dr Pieterjan Vanclooster discuss and comment on the data of two studies in salivary gland cancer presented at ESMO 2024.
Head & neck poster selection
Despite multimodal treatment, half of the patients with locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) will suffer a disease recurrence. To mitigate this risk of
During ESMO 2024, Dr Natasha Honoré (Cliniques Universitaires St.-Luc, Brussels) presented the results of a study evaluating the potential of ctDNA to predict recurrences in these patients.
Made possible with the financial support of our partners.
All videos are developed independently and are non-promotional.